Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2025-08-07 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
职工代表董事任命公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the appointment of a new employee representative director (职工代表董事任命公告) at Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the election process, compliance with legal and regulatory requirements, and includes a brief biography of the appointed director. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no indication of a report or meeting materials. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-08-07 Chinese
证券事务代表任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a securities affairs representative at Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the appointment decision made by the board, the qualifications of the appointee, and compliance with relevant laws. There is no financial data, no report or presentation attached, and no mention of voting results or other report types. This fits the category of Board/Management Information (MANG), as it concerns a change in company personnel related to securities affairs representation.
2025-08-07 Chinese
董事、高级管理人员持股变动管理制度
Governance Information Classification · 95% confidence The document is titled '董事、高级管理人员持股变动管理制度' which translates to 'Management System for Shareholding Changes of Directors and Senior Management'. It details internal rules and procedures regarding the shareholding and share transactions of the company's directors and senior management, including restrictions, reporting requirements, and compliance with securities laws. It is a governance-related document focusing on internal management policies rather than financial results, audit, or announcements of meetings or votes. It does not contain financial statements or earnings data, nor is it a report publication announcement or regulatory filing. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-07 Chinese
利润分配管理制度
Board/Management Information Classification · 95% confidence The document is titled '利润分配管理制度' which translates to 'Profit Distribution Management System'. It details the company's internal policies and procedures regarding profit distribution, dividend policies, decision-making processes, and shareholder rights. It includes references to board meetings, shareholder meetings, and legal compliance but does not contain financial statements or actual financial results. The document is a detailed internal management policy rather than a financial report or announcement of voting results. It is not a report publication announcement since it contains substantive content rather than a brief notice. It is not a regulatory filing or certification letter. The document fits best under Board/Management Information (MANG) as it relates to internal governance and management policies approved by the board and to be submitted to shareholders for approval.
2025-08-07 Chinese
内幕信息知情人登记管理制度
Governance Information Classification · 95% confidence The document is titled as an "Insider Information Insider Registration Management System" issued by the board of directors of Sichuan Zitonggong Pharmaceutical Co., Ltd. It details internal management rules and procedures related to insider information registration, confidentiality, and compliance with securities laws and regulations. The document includes sections on the scope of insider information, responsibilities of insiders, confidentiality obligations, and reporting requirements. It is a regulatory compliance and governance-related internal policy document rather than a financial report, earnings release, or announcement of voting results. It does not contain financial statements, audit opinions, or shareholder meeting materials. It is not a report publication announcement either, as it is substantive and over 5,000 characters. The document fits best under Governance Information (CGR) as it details the company's internal rules and governance practices regarding insider information management.
2025-08-07 Chinese
重大信息内部报告制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '重大信息内部报告制度' (Major Information Internal Reporting System) issued by the company's board. It outlines procedures, responsibilities, and definitions related to the internal reporting of major information within the company. It includes governance and compliance details but does not contain financial statements, earnings data, or shareholder voting results. It is not an announcement of a report but a governance/internal management document. Therefore, it fits best under Governance Information (CGR). The document length (6443 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2025-08-07 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.